ArticleLipids2026

Impact of CYP2C19 Genotype Variants on PCSK9 Inhibitor Efficacy in Lipid-Lowering Among Patients With Symptomatic Intracranial Atherosclerotic Stenosis.

Chao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.